nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ALB—Prednisone—ankylosing spondylitis	0.174	0.346	CbGbCtD
Gliclazide—CYP2C19—Prednisone—ankylosing spondylitis	0.113	0.224	CbGbCtD
Gliclazide—ALB—Methotrexate—ankylosing spondylitis	0.0874	0.174	CbGbCtD
Gliclazide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0705	0.14	CbGbCtD
Gliclazide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0586	0.116	CbGbCtD
Gliclazide—VEGFA—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.0019	0.105	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.0019	0.105	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00187	0.104	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00187	0.104	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00183	0.101	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00183	0.101	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisone—ankylosing spondylitis	0.00174	0.0961	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisone—ankylosing spondylitis	0.00174	0.0961	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00169	0.0938	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisolone—ankylosing spondylitis	0.00169	0.0938	CbGdCrCtD
Gliclazide—Hypertension—Triamcinolone—ankylosing spondylitis	0.000729	0.00152	CcSEcCtD
Gliclazide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000727	0.00152	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000724	0.00151	CcSEcCtD
Gliclazide—Myalgia—Triamcinolone—ankylosing spondylitis	0.000718	0.0015	CcSEcCtD
Gliclazide—Pneumonia—Methotrexate—ankylosing spondylitis	0.000717	0.0015	CcSEcCtD
Gliclazide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000717	0.0015	CcSEcCtD
Gliclazide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000717	0.0015	CcSEcCtD
Gliclazide—Eye disorder—Prednisone—ankylosing spondylitis	0.000716	0.0015	CcSEcCtD
Gliclazide—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000714	0.00149	CcSEcCtD
Gliclazide—Drowsiness—Methotrexate—ankylosing spondylitis	0.000713	0.00149	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000712	0.00149	CcSEcCtD
Gliclazide—Depression—Methotrexate—ankylosing spondylitis	0.000711	0.00149	CcSEcCtD
Gliclazide—Flushing—Prednisone—ankylosing spondylitis	0.000711	0.00149	CcSEcCtD
Gliclazide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00071	0.00149	CcSEcCtD
Gliclazide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00071	0.00149	CcSEcCtD
Gliclazide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00071	0.00148	CcSEcCtD
Gliclazide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000708	0.00148	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000707	0.00148	CcSEcCtD
Gliclazide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000703	0.00147	CcSEcCtD
Gliclazide—Renal failure—Methotrexate—ankylosing spondylitis	0.000701	0.00147	CcSEcCtD
Gliclazide—Angioedema—Dexamethasone—ankylosing spondylitis	0.0007	0.00146	CcSEcCtD
Gliclazide—Angioedema—Betamethasone—ankylosing spondylitis	0.0007	0.00146	CcSEcCtD
Gliclazide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000693	0.00145	CcSEcCtD
Gliclazide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000693	0.00145	CcSEcCtD
Gliclazide—Malaise—Dexamethasone—ankylosing spondylitis	0.00069	0.00144	CcSEcCtD
Gliclazide—Malaise—Betamethasone—ankylosing spondylitis	0.00069	0.00144	CcSEcCtD
Gliclazide—Arrhythmia—Prednisone—ankylosing spondylitis	0.000684	0.00143	CcSEcCtD
Gliclazide—Infection—Triamcinolone—ankylosing spondylitis	0.000684	0.00143	CcSEcCtD
Gliclazide—Sweating—Methotrexate—ankylosing spondylitis	0.000684	0.00143	CcSEcCtD
Gliclazide—Infection—Methylprednisolone—ankylosing spondylitis	0.000683	0.00143	CcSEcCtD
Gliclazide—Insomnia—Prednisolone—ankylosing spondylitis	0.000677	0.00142	CcSEcCtD
Gliclazide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000674	0.00141	CcSEcCtD
Gliclazide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000674	0.00141	CcSEcCtD
Gliclazide—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000673	0.00141	CcSEcCtD
Gliclazide—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000673	0.00141	CcSEcCtD
Gliclazide—Epistaxis—Methotrexate—ankylosing spondylitis	0.000673	0.00141	CcSEcCtD
Gliclazide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000672	0.00141	CcSEcCtD
Gliclazide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000672	0.00141	CcSEcCtD
Gliclazide—Mental disorder—Prednisone—ankylosing spondylitis	0.000671	0.0014	CcSEcCtD
Gliclazide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000671	0.0014	CcSEcCtD
Gliclazide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000667	0.0014	CcSEcCtD
Gliclazide—Malnutrition—Prednisone—ankylosing spondylitis	0.000667	0.00139	CcSEcCtD
Gliclazide—Erythema—Prednisone—ankylosing spondylitis	0.000667	0.00139	CcSEcCtD
Gliclazide—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000666	0.00139	CcSEcCtD
Gliclazide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000665	0.00139	CcSEcCtD
Gliclazide—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000664	0.00139	CcSEcCtD
Gliclazide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000663	0.00139	CcSEcCtD
Gliclazide—Convulsion—Betamethasone—ankylosing spondylitis	0.000663	0.00139	CcSEcCtD
Gliclazide—Hypertension—Betamethasone—ankylosing spondylitis	0.000661	0.00138	CcSEcCtD
Gliclazide—Hypertension—Dexamethasone—ankylosing spondylitis	0.000661	0.00138	CcSEcCtD
Gliclazide—Myalgia—Dexamethasone—ankylosing spondylitis	0.000652	0.00136	CcSEcCtD
Gliclazide—Myalgia—Betamethasone—ankylosing spondylitis	0.000652	0.00136	CcSEcCtD
Gliclazide—Anxiety—Betamethasone—ankylosing spondylitis	0.00065	0.00136	CcSEcCtD
Gliclazide—Anxiety—Dexamethasone—ankylosing spondylitis	0.00065	0.00136	CcSEcCtD
Gliclazide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000644	0.00135	CcSEcCtD
Gliclazide—Discomfort—Betamethasone—ankylosing spondylitis	0.000644	0.00135	CcSEcCtD
Gliclazide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000642	0.00134	CcSEcCtD
Gliclazide—Pain—Prednisolone—ankylosing spondylitis	0.00064	0.00134	CcSEcCtD
Gliclazide—Hepatitis—Methotrexate—ankylosing spondylitis	0.00064	0.00134	CcSEcCtD
Gliclazide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000635	0.00133	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000627	0.00131	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000626	0.00131	CcSEcCtD
Gliclazide—Insomnia—Triamcinolone—ankylosing spondylitis	0.000623	0.0013	CcSEcCtD
Gliclazide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000621	0.0013	CcSEcCtD
Gliclazide—Infection—Betamethasone—ankylosing spondylitis	0.000621	0.0013	CcSEcCtD
Gliclazide—Infection—Dexamethasone—ankylosing spondylitis	0.000621	0.0013	CcSEcCtD
Gliclazide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000619	0.00129	CcSEcCtD
Gliclazide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000618	0.00129	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000617	0.00129	CcSEcCtD
Gliclazide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000617	0.00129	CcSEcCtD
Gliclazide—Visual impairment—Methotrexate—ankylosing spondylitis	0.000617	0.00129	CcSEcCtD
Gliclazide—Anaemia—Prednisone—ankylosing spondylitis	0.000616	0.00129	CcSEcCtD
Gliclazide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000614	0.00128	CcSEcCtD
Gliclazide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000613	0.00128	CcSEcCtD
Gliclazide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000613	0.00128	CcSEcCtD
Gliclazide—Agitation—Prednisone—ankylosing spondylitis	0.000613	0.00128	CcSEcCtD
Gliclazide—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000612	0.00128	CcSEcCtD
Gliclazide—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000612	0.00128	CcSEcCtD
Gliclazide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00061	0.00127	CcSEcCtD
Gliclazide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00061	0.00127	CcSEcCtD
Gliclazide—Angioedema—Prednisone—ankylosing spondylitis	0.000609	0.00127	CcSEcCtD
Gliclazide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000606	0.00127	CcSEcCtD
Gliclazide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000605	0.00127	CcSEcCtD
Gliclazide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000605	0.00126	CcSEcCtD
Gliclazide—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000604	0.00126	CcSEcCtD
Gliclazide—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000604	0.00126	CcSEcCtD
Gliclazide—Malaise—Prednisone—ankylosing spondylitis	0.000601	0.00126	CcSEcCtD
Gliclazide—Eye disorder—Methotrexate—ankylosing spondylitis	0.000598	0.00125	CcSEcCtD
Gliclazide—Tinnitus—Methotrexate—ankylosing spondylitis	0.000597	0.00125	CcSEcCtD
Gliclazide—Urticaria—Prednisolone—ankylosing spondylitis	0.000595	0.00124	CcSEcCtD
Gliclazide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000594	0.00124	CcSEcCtD
Gliclazide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000592	0.00124	CcSEcCtD
Gliclazide—Pain—Triamcinolone—ankylosing spondylitis	0.000589	0.00123	CcSEcCtD
Gliclazide—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000586	0.00123	CcSEcCtD
Gliclazide—Hypotension—Betamethasone—ankylosing spondylitis	0.000584	0.00122	CcSEcCtD
Gliclazide—Hypotension—Dexamethasone—ankylosing spondylitis	0.000584	0.00122	CcSEcCtD
Gliclazide—Convulsion—Prednisone—ankylosing spondylitis	0.000578	0.00121	CcSEcCtD
Gliclazide—Hypertension—Prednisone—ankylosing spondylitis	0.000576	0.0012	CcSEcCtD
Gliclazide—Chills—Methotrexate—ankylosing spondylitis	0.000574	0.0012	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000569	0.00119	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000569	0.00119	CcSEcCtD
Gliclazide—Arthralgia—Prednisone—ankylosing spondylitis	0.000568	0.00119	CcSEcCtD
Gliclazide—Myalgia—Prednisone—ankylosing spondylitis	0.000568	0.00119	CcSEcCtD
Gliclazide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000568	0.00119	CcSEcCtD
Gliclazide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000566	0.00118	CcSEcCtD
Gliclazide—Anxiety—Prednisone—ankylosing spondylitis	0.000566	0.00118	CcSEcCtD
Gliclazide—Insomnia—Betamethasone—ankylosing spondylitis	0.000565	0.00118	CcSEcCtD
Gliclazide—Insomnia—Dexamethasone—ankylosing spondylitis	0.000565	0.00118	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000564	0.00118	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000562	0.00117	CcSEcCtD
Gliclazide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000561	0.00117	CcSEcCtD
Gliclazide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000561	0.00117	CcSEcCtD
Gliclazide—Discomfort—Prednisone—ankylosing spondylitis	0.000561	0.00117	CcSEcCtD
Gliclazide—Mental disorder—Methotrexate—ankylosing spondylitis	0.000561	0.00117	CcSEcCtD
Gliclazide—Erythema—Methotrexate—ankylosing spondylitis	0.000557	0.00116	CcSEcCtD
Gliclazide—Malnutrition—Methotrexate—ankylosing spondylitis	0.000557	0.00116	CcSEcCtD
Gliclazide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000552	0.00115	CcSEcCtD
Gliclazide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00055	0.00115	CcSEcCtD
Gliclazide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00055	0.00115	CcSEcCtD
Gliclazide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000547	0.00114	CcSEcCtD
Gliclazide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000546	0.00114	CcSEcCtD
Gliclazide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000544	0.00114	CcSEcCtD
Gliclazide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000543	0.00114	CcSEcCtD
Gliclazide—Infection—Prednisone—ankylosing spondylitis	0.000541	0.00113	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000539	0.00113	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000539	0.00113	CcSEcCtD
Gliclazide—Back pain—Methotrexate—ankylosing spondylitis	0.000539	0.00113	CcSEcCtD
Gliclazide—Fatigue—Betamethasone—ankylosing spondylitis	0.000539	0.00113	CcSEcCtD
Gliclazide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000539	0.00113	CcSEcCtD
Gliclazide—Pain—Dexamethasone—ankylosing spondylitis	0.000534	0.00112	CcSEcCtD
Gliclazide—Pain—Betamethasone—ankylosing spondylitis	0.000534	0.00112	CcSEcCtD
Gliclazide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000534	0.00112	CcSEcCtD
Gliclazide—Tachycardia—Prednisone—ankylosing spondylitis	0.000531	0.00111	CcSEcCtD
Gliclazide—Skin disorder—Prednisone—ankylosing spondylitis	0.000529	0.00111	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000526	0.0011	CcSEcCtD
Gliclazide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000517	0.00108	CcSEcCtD
Gliclazide—Anaemia—Methotrexate—ankylosing spondylitis	0.000515	0.00108	CcSEcCtD
Gliclazide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000515	0.00108	CcSEcCtD
Gliclazide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000515	0.00108	CcSEcCtD
Gliclazide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000511	0.00107	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000511	0.00107	CcSEcCtD
Gliclazide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000507	0.00106	CcSEcCtD
Gliclazide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000506	0.00106	CcSEcCtD
Gliclazide—Malaise—Methotrexate—ankylosing spondylitis	0.000503	0.00105	CcSEcCtD
Gliclazide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000499	0.00104	CcSEcCtD
Gliclazide—Urticaria—Betamethasone—ankylosing spondylitis	0.000496	0.00104	CcSEcCtD
Gliclazide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000496	0.00104	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000496	0.00104	CcSEcCtD
Gliclazide—Dizziness—Prednisolone—ankylosing spondylitis	0.000495	0.00104	CcSEcCtD
Gliclazide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000494	0.00103	CcSEcCtD
Gliclazide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000494	0.00103	CcSEcCtD
Gliclazide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000494	0.00103	CcSEcCtD
Gliclazide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000494	0.00103	CcSEcCtD
Gliclazide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000494	0.00103	CcSEcCtD
Gliclazide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000493	0.00103	CcSEcCtD
Gliclazide—Insomnia—Prednisone—ankylosing spondylitis	0.000492	0.00103	CcSEcCtD
Gliclazide—Paraesthesia—Prednisone—ankylosing spondylitis	0.000489	0.00102	CcSEcCtD
Gliclazide—Pruritus—Triamcinolone—ankylosing spondylitis	0.000487	0.00102	CcSEcCtD
Gliclazide—Cough—Methotrexate—ankylosing spondylitis	0.000486	0.00102	CcSEcCtD
Gliclazide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000486	0.00102	CcSEcCtD
Gliclazide—Convulsion—Methotrexate—ankylosing spondylitis	0.000483	0.00101	CcSEcCtD
Gliclazide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000479	0.001	CcSEcCtD
Gliclazide—Arthralgia—Methotrexate—ankylosing spondylitis	0.000474	0.000992	CcSEcCtD
Gliclazide—Myalgia—Methotrexate—ankylosing spondylitis	0.000474	0.000992	CcSEcCtD
Gliclazide—Chest pain—Methotrexate—ankylosing spondylitis	0.000474	0.000992	CcSEcCtD
Gliclazide—Rash—Prednisolone—ankylosing spondylitis	0.000472	0.000987	CcSEcCtD
Gliclazide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000472	0.000986	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000471	0.000985	CcSEcCtD
Gliclazide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00047	0.000983	CcSEcCtD
Gliclazide—Fatigue—Prednisone—ankylosing spondylitis	0.000469	0.000981	CcSEcCtD
Gliclazide—Headache—Prednisolone—ankylosing spondylitis	0.000469	0.000981	CcSEcCtD
Gliclazide—Discomfort—Methotrexate—ankylosing spondylitis	0.000469	0.00098	CcSEcCtD
Gliclazide—Constipation—Prednisone—ankylosing spondylitis	0.000465	0.000973	CcSEcCtD
Gliclazide—Confusional state—Methotrexate—ankylosing spondylitis	0.000459	0.000959	CcSEcCtD
Gliclazide—Dizziness—Triamcinolone—ankylosing spondylitis	0.000455	0.000952	CcSEcCtD
Gliclazide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000454	0.00095	CcSEcCtD
Gliclazide—Infection—Methotrexate—ankylosing spondylitis	0.000452	0.000945	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000448	0.000937	CcSEcCtD
Gliclazide—Asthenia—Betamethasone—ankylosing spondylitis	0.000448	0.000937	CcSEcCtD
Gliclazide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000448	0.000937	CcSEcCtD
Gliclazide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000446	0.000932	CcSEcCtD
Gliclazide—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000445	0.000931	CcSEcCtD
Gliclazide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000445	0.00093	CcSEcCtD
Gliclazide—Nausea—Prednisolone—ankylosing spondylitis	0.000445	0.00093	CcSEcCtD
Gliclazide—Pruritus—Betamethasone—ankylosing spondylitis	0.000442	0.000924	CcSEcCtD
Gliclazide—Pruritus—Dexamethasone—ankylosing spondylitis	0.000442	0.000924	CcSEcCtD
Gliclazide—Skin disorder—Methotrexate—ankylosing spondylitis	0.000442	0.000924	CcSEcCtD
Gliclazide—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00044	0.000919	CcSEcCtD
Gliclazide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000438	0.000915	CcSEcCtD
Gliclazide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000437	0.000913	CcSEcCtD
Gliclazide—Rash—Triamcinolone—ankylosing spondylitis	0.000434	0.000908	CcSEcCtD
Gliclazide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000434	0.000907	CcSEcCtD
Gliclazide—Rash—Methylprednisolone—ankylosing spondylitis	0.000433	0.000906	CcSEcCtD
Gliclazide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000433	0.000905	CcSEcCtD
Gliclazide—Urticaria—Prednisone—ankylosing spondylitis	0.000432	0.000904	CcSEcCtD
Gliclazide—Headache—Triamcinolone—ankylosing spondylitis	0.000431	0.000902	CcSEcCtD
Gliclazide—Headache—Methylprednisolone—ankylosing spondylitis	0.00043	0.0009	CcSEcCtD
Gliclazide—Body temperature increased—Prednisone—ankylosing spondylitis	0.00043	0.000899	CcSEcCtD
Gliclazide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00043	0.000899	CcSEcCtD
Gliclazide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000428	0.000894	CcSEcCtD
Gliclazide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000428	0.000894	CcSEcCtD
Gliclazide—Hypotension—Methotrexate—ankylosing spondylitis	0.000425	0.000888	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000414	0.000866	CcSEcCtD
Gliclazide—Dizziness—Betamethasone—ankylosing spondylitis	0.000413	0.000864	CcSEcCtD
Gliclazide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000413	0.000864	CcSEcCtD
Gliclazide—Insomnia—Methotrexate—ankylosing spondylitis	0.000411	0.00086	CcSEcCtD
Gliclazide—Nausea—Triamcinolone—ankylosing spondylitis	0.000409	0.000855	CcSEcCtD
Gliclazide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000408	0.000854	CcSEcCtD
Gliclazide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000408	0.000853	CcSEcCtD
Gliclazide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000405	0.000848	CcSEcCtD
Gliclazide—Somnolence—Methotrexate—ankylosing spondylitis	0.000404	0.000845	CcSEcCtD
Gliclazide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000401	0.000838	CcSEcCtD
Gliclazide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.0004	0.000837	CcSEcCtD
Gliclazide—Vomiting—Betamethasone—ankylosing spondylitis	0.000397	0.000831	CcSEcCtD
Gliclazide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000397	0.000831	CcSEcCtD
Gliclazide—Rash—Dexamethasone—ankylosing spondylitis	0.000394	0.000824	CcSEcCtD
Gliclazide—Rash—Betamethasone—ankylosing spondylitis	0.000394	0.000824	CcSEcCtD
Gliclazide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000394	0.000823	CcSEcCtD
Gliclazide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000394	0.000823	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000393	0.000821	CcSEcCtD
Gliclazide—Fatigue—Methotrexate—ankylosing spondylitis	0.000392	0.00082	CcSEcCtD
Gliclazide—Headache—Dexamethasone—ankylosing spondylitis	0.000391	0.000818	CcSEcCtD
Gliclazide—Headache—Betamethasone—ankylosing spondylitis	0.000391	0.000818	CcSEcCtD
Gliclazide—Asthenia—Prednisone—ankylosing spondylitis	0.00039	0.000816	CcSEcCtD
Gliclazide—Pain—Methotrexate—ankylosing spondylitis	0.000389	0.000813	CcSEcCtD
Gliclazide—Pruritus—Prednisone—ankylosing spondylitis	0.000385	0.000805	CcSEcCtD
Gliclazide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000375	0.000783	CcSEcCtD
Gliclazide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000372	0.000778	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000372	0.000777	CcSEcCtD
Gliclazide—Nausea—Dexamethasone—ankylosing spondylitis	0.000371	0.000776	CcSEcCtD
Gliclazide—Nausea—Betamethasone—ankylosing spondylitis	0.000371	0.000776	CcSEcCtD
Gliclazide—Urticaria—Methotrexate—ankylosing spondylitis	0.000361	0.000755	CcSEcCtD
Gliclazide—Dizziness—Prednisone—ankylosing spondylitis	0.00036	0.000752	CcSEcCtD
Gliclazide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00036	0.000752	CcSEcCtD
Gliclazide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00036	0.000752	CcSEcCtD
Gliclazide—Vomiting—Prednisone—ankylosing spondylitis	0.000346	0.000723	CcSEcCtD
Gliclazide—Rash—Prednisone—ankylosing spondylitis	0.000343	0.000717	CcSEcCtD
Gliclazide—Dermatitis—Prednisone—ankylosing spondylitis	0.000343	0.000717	CcSEcCtD
Gliclazide—Headache—Prednisone—ankylosing spondylitis	0.000341	0.000713	CcSEcCtD
Gliclazide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000335	0.0007	CcSEcCtD
Gliclazide—Asthenia—Methotrexate—ankylosing spondylitis	0.000326	0.000682	CcSEcCtD
Gliclazide—Nausea—Prednisone—ankylosing spondylitis	0.000323	0.000676	CcSEcCtD
Gliclazide—Pruritus—Methotrexate—ankylosing spondylitis	0.000322	0.000673	CcSEcCtD
Gliclazide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000311	0.000651	CcSEcCtD
Gliclazide—Dizziness—Methotrexate—ankylosing spondylitis	0.000301	0.000629	CcSEcCtD
Gliclazide—Vomiting—Methotrexate—ankylosing spondylitis	0.000289	0.000605	CcSEcCtD
Gliclazide—Rash—Methotrexate—ankylosing spondylitis	0.000287	0.000599	CcSEcCtD
Gliclazide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000286	0.000599	CcSEcCtD
Gliclazide—Headache—Methotrexate—ankylosing spondylitis	0.000285	0.000596	CcSEcCtD
Gliclazide—Nausea—Methotrexate—ankylosing spondylitis	0.00027	0.000565	CcSEcCtD
